Hantz Financial Services’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
SC
FLAM
GKIM
PIM
Hantz Financial Services's TNDM Position: Q2 2026 in Review
Hantz Financial Services increased its Tandem Diabetes Care (TNDM) stake by 15% in Q2 2026, buying an estimated $1.87K and bringing the position to 828 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #2052.
Hantz Financial Services first reported a position in TNDM in Q1 2025 and has held it in 6 quarters since. The position peaked at $16K in Q4 2025. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.
- Hantz Financial Services held 828 shares of Tandem Diabetes Care worth $12K as of Q2 2026.
- Hantz Financial Services bought 107 Tandem Diabetes Care shares in Q2 2026, an estimated $1.87K.
- Tandem Diabetes Care made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #2052 holding.
- Hantz Financial Services first reported a position in Tandem Diabetes Care in Q1 2025 and has held it in 6 quarters since.
- Hantz Financial Services's Tandem Diabetes Care position peaked at $16K in Q4 2025.
- 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.
Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.